Rover Group (ROVR) Announces Redemption of Public Warrants
by Marlena Haddad on 2021-12-13 at 5:40pm

Rover Group (NASDAQ:ROVR) announced this afternoon that it will redeem all outstanding warrants at a price of $0.10 per Warrant at 5 pm EST, January 12, 2022, and the Warrants may be exercised by the holders until 5:00 p.m. New York City time on the Redemption Date to purchase the Common Stock underlying the Warrants on a cash or cashless basis.

However, if they are purchased on a “cashless basis”, the number of shares to be received will be calculated by taking the VWAP during the 10 trading days immediately following the date on which the notice of redemption is sent to warrant holders. The Company will inform holders of the Fair Market Value no later than one business day after the 10-trading day period ends. In no event will the number of shares of Common Stock issued in connection with an exercise on a cashless basis exceed 0.361 shares of Common Stock per Warrant, but that looks unlikely given where the share is currently trading.

Additionally, Rover will redeem all of its outstanding warrants to purchase shares of common stock that were issued under the warrant agreement in a private placement simultaneously with the IPO on the same terms as the outstanding public warrants.

The company, which closed its combination with Nebula Caravel in late July, is allowed under its warrant agreement to call all warrants at a redemption price of $0.10 if its share price has been at least $10 for 20 of 30 trading days ending on the third business day prior to the date on which a notice of redemption is given. Rover met that requirement on December 8 and December 10, 2021.

Any warrants that remain unexercised at 5:00 p.m. EST on the redemption date will be void and no longer exercisable, and holders will be entitled to receive only the redemption price of $0.10 per  warrant.

 

Rover Group (ROVR) Announces Redemption of Public Warrants
Recent Posts
by Nicholas Alan Clayton on 2025-07-01 at 11:33am

Ribbon (NASDAQ:RIBB) has entered into a definitive agreement to combine with Japanese biotech firm DRC Medicine at a pro forma equity value of $422 million. Tokyo-based DRC Medicine manufactures reusable anti-bacterial and anti-allergen wearables and aims to go deeper into the medical device and pharmaceutical space. Transaction Overview Ribbon is expected to provide $50.4 million...

by Henrique Santa Rosa, CFA on 2025-07-01 at 11:09am

In June 2025, the SPAC market was marked by a notable rise in meeting delays, with adjournments and postponements playing a central role in extension activity, as sponsors navigated a more cautious market environment. Still, several SPACs secured shareholder approvals, and seven business combinations were completed during the month. At the same time, IPO issuance...

by Kristi Marvin on 2025-07-01 at 8:42am

An In-Depth Look at SPAC Activity Through the Second Quarter & First Half 2025 Below is a summary of the first half of 2025 SPAC market. If you’d like a pdf copy, you can access the link HERE. Q2 kicked off in chaos. President Trump’s shifting and often contradictory tariff announcements sent markets reeling, driving...

by Nicholas Alan Clayton on 2025-07-01 at 8:25am

At the SPAC of Dawn The market is set to be showered with new SPACs today as three more SPACs priced their IPOs overnight, bringing 2025’s total to 66, already surpassing the full-year total of 2024. After hours, Ribbon (NASDAQ:RIBB) also added a new SPAC deal to June’s tally just under the wire, bringing the...

by Nicholas Alan Clayton on 2025-06-30 at 9:04pm

NMP Acquisition Corp. (NASDAQ:NMPAU) announced the pricing of its $100 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “NMPAU”, Tuesday, July 1, 2025. The new SPAC plans to combine with a target company that has a resilient business model with potential to scale up revenue. NMP’s management...

logo

Copyright © 2025 SPACInsider, Inc. All Rights Reserved